Related references
Note: Only part of the references are listed.Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
Mari Nygard et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States
Vincent Daniels et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
Jane J. Kim et al.
PLOS MEDICINE (2021)
Age at first intercourse, number of partners and sexually transmitted infection prevalence among Danish, Norwegian and Swedish women: estimates and trends from nationally representative cross-sectional surveys of more than 100 000 women
Bo T. Hansen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)
Human papillomavirus vaccination coverage, policies, and practical implementation across Europe
Ngoc-Ha Nguyen-Huu et al.
VACCINE (2020)
Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study
Jiangrong Wang et al.
PREVENTIVE MEDICINE (2019)
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Tim Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
Parental perceptions of human papillomavirus vaccination in central China: the moderating role of socioeconomic factors
Min Zhou et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Human papillomavirus vaccine disease impact beyond expectations
Silvia de Sanjose et al.
CURRENT OPINION IN VIROLOGY (2019)
A systematic review of factors influencing human papillomavirus vaccination among immigrant parents in the United States
Kyounghae Kim et al.
HEALTH CARE FOR WOMEN INTERNATIONAL (2019)
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
M. Arbyn et al.
EXPERT REVIEW OF VACCINES (2018)
Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study
Teresa Kreusch et al.
BMJ OPEN (2018)
Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
Silvia de Sanjose et al.
JNCI CANCER SPECTRUM (2018)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial
Warner K. Huh et al.
LANCET (2017)
Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour
Maria Grandahl et al.
PLOS ONE (2017)
The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review
Alice Yuen Loke et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2017)
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Cosette M. Wheeler et al.
LANCET INFECTIOUS DISEASES (2016)
Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia
Iris L. Y. Tung et al.
PLOS ONE (2016)
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
Laia Bruni et al.
LANCET GLOBAL HEALTH (2016)
Socioeconomic Predictors of Human Papillomavirus Vaccination Among Girls in the Danish Childhood Immunization Program
Selma Marie Slattelid Schreiber et al.
JOURNAL OF ADOLESCENT HEALTH (2015)
Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents
Bo Terning Hansen et al.
PREVENTIVE MEDICINE (2015)
Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study
Karen Canfell et al.
VACCINE (2015)
Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway
Bent Feiring et al.
BMJ OPEN (2015)
Too Late to Vaccinate? The Incremental Benefits and Cost-effectiveness of a Delayed Catch-up Program Using the 4-Valent Human Papillomavirus Vaccine in Norway
Emily A. Burger et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Predicting human papillomavirus vaccination behaviour among adolescent girls in England: results from a prospective survey
Harriet L. Bowyer et al.
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2014)
Barriers to Human Papillomavirus Vaccination Among US Adolescents A Systematic Review of the Literature
Dawn M. Holman et al.
JAMA PEDIATRICS (2014)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen et al.
LANCET ONCOLOGY (2012)
Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries
Karen Canfell et al.
VACCINE (2012)
Factors associated with HPV vaccine uptake in teenage girls: A systematic review
Sharon J. M. Kessels et al.
VACCINE (2012)
Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
Marc Rondy et al.
VACCINE (2010)
Ethnic differences in human papillomavirus awareness and vaccine acceptability
L. A. V. Marlow et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2009)
Social determinants of health inequalities
M Marmot
LANCET (2005)
Share Paper
